To lower high blood pressure (hypertension) To lower the risk of hospitalization and death due to heart failure in people with heart failure To lower the risk of developing heart failure and being ...
Please provide your email address to receive an email when new articles are posted on . Enalapril was not superior to standard care for preventing chemotherapy-related cardiotoxicity for breast cancer ...
Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction Enalapril treatment did not ...
Athens, Greece - A dose-response study of the ACE-inhibitor enalapril (Vasotec® - Merck) in congestive heart failure (CHF) patients found no difference in survival and clinical status in patients ...
In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results